The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.
about
Parenteral fluid regimens for improving functional outcome in people with acute strokeHaemodilution for acute ischaemic strokeAlbumin and multiple sclerosisNeuroprotection for stroke: current status and future perspectivesHigh-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials.The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysisFlow Augmentation in Acute Ischemic Stroke.Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rate.New avenues for treatment of intracranial hemorrhage.Potential serum biomarkers in the pathophysiological processes of strokeIn my opinion: serum albumin should be maintained during neurocritical care.Current perspectives on potential role of albumin in neuroprotection.A review of the use of human albumin in burn patients.Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.Effect of waivers of consent on recruitment in acute stroke trials: A systematic reviewDeveloping drug strategies for the neuroprotective treatment of acute ischemic stroke.An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats.Time for a neurorestorative therapy in stroke.Albumin-Induced Neuroprotection in Focal Cerebral Ischemia in the ALIAS Trial: Does Severity, Mechanism, and Time of Infusion Matter?
P2860
Q24187382-044FE872-4D55-4BFA-9177-AFC868413801Q24194279-9518DBFF-6E71-434E-A649-1DB95F6464E8Q26749307-99F15F26-BF7A-4670-BE09-05B52173A59FQ26853031-689C4DF2-0643-4495-A79D-82FDB3B64675Q30572344-5CBB59BE-E74D-48E2-ABB1-DC9314F4B39CQ31117815-E9050B4B-BE3E-4334-B41A-1BE9A050C449Q33772181-636EBDF2-E0BF-4EC5-87BE-A869B0407840Q34959376-472A395E-9D65-41BF-A860-2B05F23DDE24Q35055490-D0EB6779-7086-4812-9B11-9E0F5E8C62EBQ35490685-20A48E67-9A69-4857-92BD-7790D8D7C82AQ35611490-9F5900A5-DE2D-4E5C-A8E6-B26E2CBDA964Q35760931-32F663F3-2392-4981-96B4-30A6BF078AA8Q36322674-5DFA6801-65C7-488C-9755-9B88EC9C6686Q37598901-FD90134B-0457-4247-8951-CFDF74BB64C6Q37612222-673AE1DB-A47E-4EB2-8F5B-149E9C66ADB7Q37846552-4B759197-4D3C-4EA1-B7CD-284C4BBDB759Q37876893-B2528229-66C9-445A-BB48-7B8750294700Q38059163-D9542BA8-5EED-4D77-A25A-633B8DC50E18Q38100263-6987C3DC-62AF-4B83-AB12-3E53E77AB418Q38786616-E8A86F07-5C6A-4ABB-9A86-49B09F05DF7FQ40429078-E3379B5B-6C55-40CB-A3A7-9073725030A8Q40523644-EFCE41EA-BAF4-4F64-9214-C7EF90909EB0Q41845026-21750284-2BD1-4944-B778-F36CEE33DB0AQ46192004-647D6CA7-9F2B-48E5-8A19-2EC9346154D7Q50703442-D23AA8C8-A65F-4EA3-A10C-BC48EEA78A47
P2860
The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The albumin in acute stroke (A ...... ationale and design of part 2.
@ast
The albumin in acute stroke (A ...... ationale and design of part 2.
@en
type
label
The albumin in acute stroke (A ...... ationale and design of part 2.
@ast
The albumin in acute stroke (A ...... ationale and design of part 2.
@en
prefLabel
The albumin in acute stroke (A ...... ationale and design of part 2.
@ast
The albumin in acute stroke (A ...... ationale and design of part 2.
@en
P2093
P2860
P1433
P1476
The albumin in acute stroke (A ...... ationale and design of part 2.
@en
P2093
ALIAS Investigators
Bonnie D Waldman
Claudia S Moy
Diego Tamariz
Karla Ryckborst
Myron D Ginsberg
Renee H Martin
Sharon D Yeatts
Yuko Y Palesch
P2860
P304
P356
10.1161/STROKEAHA.110.596072
P407
P577
2010-12-16T00:00:00Z